GT Biopharma GTBP
NASDAQ GTBP
$6.15 -0.32 (-4.95%)
As of: Oct 1, 2026 · 10:10 AM EDT

GT Biopharma (GTBP) Capital Expenditures (2017 - 2018)

Updated

GT Biopharma's Capital Expenditures was $32,000 in Q4 2018, up 700.0% from $4,000 a year earlier.

Analysis

GT Biopharma (GTBP) Capital Expenditures (2017 - 2018) Analysis & Trends

For FY2018, Capital Expenditures at GT Biopharma came in at $36,000, up 800.0% from FY2017.

  • Capital Expenditures shows a four-year compound annual growth rate of 56.5% (FY2014 to FY2018).
  • In earlier years, Capital Expenditures was $4,000 in FY2017, $1,000 in FY2015 (-83.3%) and $6,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 GT Biopharma 9.11 Mn 9.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 32,000.00
Sep 30, 2018 2,000.00
Mar 31, 2018 2,000.00
Dec 31, 2017 4,000.00
API Access

GT Biopharma Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GTBP&period=max&api_key=YOUR_API_KEY